EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of prolactin receptor variants with diverse effects on receptor signalling

Caroline M Gorvin iD, Paul J Newey iD, Rajesh V Thakker iD

Journal of Molecular Endocrinology · 2023

DOI: 10.1530/jme-22-0164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, 2023. Verfasst von Caroline M Gorvin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Receptors, Prolactin, Hyperprolactinemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, Department of Health, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prolactin receptor (PRLR) signals predominantly through the JAK2-STAT5 pathway regulating multiple physiological functions relating to fertility, lactation, and metabolism. However, the molecular pathology and role of PRLR mutations and signalling are incompletely defined, with progress hampered by a lack of reported disease-associated PRLR variants. To date, two common germline PRLR variants are reported to demonstrate constitutive activity, with one, Ile146Leu, overrepresented in benign breast disease, while a rare activating variant, Asn492Ile, is reported to be associated with an increased incidence of prolactinoma. In contrast, an inactivating germline heterozygous PRLR variant (His188Arg) was reported in a kindred with hyperprolactinaemia, while an inactivating compound heterozygous PRLR variant (Pro269Leu/Arg171Stop) was identified in an individual with hyperprolactinaemia and agalactia. We hypothesised that additional rare germline PRLR variants, identified from large-scale sequencing projects (ExAC and GnomAD), may be associated with altered in vitro PRLR signalling activity. We therefore evaluated >300 previously uncharacterised non-synonymous, germline PRLR variants and selected 10 variants for in vitro analysis based on protein prediction algorithms, proximity to known functional domains and structural modelling. Five variants, including extracellular and intracellular domain variants, were associated with altered responses when compared to the wild-type receptor. These altered responses included loss- and gain-of-function activities related to STAT5 signalling, Akt and FOXO1 activity, as well as cell viability and apoptosis. These studies provide further insight into PRLR structure–function and indicate that rare germline PRLR variants may have diverse modulating effects on PRLR signalling, although the pathophysiologic relevance of such alterations remains to be defined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ProlactinHyperprolactinemiaFemaleHumansSTAT5 Transcription FactorSignal TransductionProlactinCarrier Proteins

Stichwörter der Autor:innen

JAK-STAT5hyperprolactinaemiaprolactinomaproliferation

Substanzen

Receptors, ProlactinSTAT5 Transcription FactorProlactinCarrier Proteins

Autor:innen und Institutionen

  • Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford NIHR Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.
  • Institute of Metabolism and Systems Research (IMSR) & Centre for Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners, University of Birmingham, Birmingham, UK.
  • Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.
  • Division of Molecular & Clinical Medicine (MCM), University of Dundee, Jacqui Wood Cancer Centre, Dundee, UK.

ORCID-Profile: Caroline M Gorvin, Paul J Newey, Rajesh V Thakker

Förderung

  • Chief Scientist Office
  • Department of Health
  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Gorvin, C. M., Newey, P. J., & Thakker, R. V. (2023). Identification of prolactin receptor variants with diverse effects on receptor signalling. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-22-0164

Vancouver

Gorvin CM, Newey PJ, Thakker RV. Identification of prolactin receptor variants with diverse effects on receptor signalling. Journal of Molecular Endocrinology. 2023. doi:10.1530/jme-22-0164

BibTeX
@article{Gorvin2023,
  author = {Gorvin, Caroline M and Newey, Paul J and Thakker, Rajesh V},
  title = {Identification of prolactin receptor variants with diverse effects on receptor signalling},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  doi = {10.1530/jme-22-0164}
}
Kostenlos starten →